The Third FRAME Toxicity Committee: Working toward greater implementation of alternatives in toxicity testing

Alternatives to Laboratory Animals

Volumn 32, Issue SUPPL. 1B, 2004, Pages 635-642

  Combes, Robert D ^a   Balls, Michael ^a   Bansil, Lee ^b   Barratt, Martin ^c   Bell, David ^d   Botham, Philip ^e   Broadhead, Caren ^a   Clothier, Richard ^d   George, Elizabeth ^f   Fentem, Julia ^g   Jackson, Michael ^o   Indans, Ian ^h   Loizou, George ⁱ   Navaratnam, Vyra ^j   Pentreath, Victor ^k   Phillips, Barry ^l   Stemplewski, Henry ^m   Stewart, Jane ⁿ  

^a RUSSELL AND BURCH HOUSE   (United Kingdom)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c Marlin Consultancy   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e JEALOTT S HILL RESEARCH STATION   (United Kingdom)

^f GLAXOSMITHKLINE   (United Kingdom)

^g UNILEVER RESEARCH   (United Kingdom)

^h HEALTH AND SAFETY EXECUTIVE   (United Kingdom)

ⁱ HEALTH AND SAFETY LABORATORY   (United Kingdom)

^j Home Office Central Research Establishment   (United Kingdom)

^k UNIVERSITY OF SALFORD   (United Kingdom)

^l Research Animals Department   (United Kingdom)

^m MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

ⁿ ASTRAZENECA   (United Kingdom)

^o Russell and Burch House ^*

more..

Author keywords

FRAME; High production volume; Three Rs; Toxicity testing; Transgenic animal models; Validation

Indexed keywords

AGRICULTURAL CHEMICAL; COSMETIC; INDUSTRIAL CHEMICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL SOCIETY; ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ANIMAL WELFARE; CONFERENCE PAPER; ENDOCRINE DISEASE; LAW; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; TOXICITY TESTING; TRANSGENIC ANIMAL; VALIDATION PROCESS;

ANIMALIA;

EID: 3042569619     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403201s107     Document Type: Conference Paper

References (33)

1. Annett, B. (1995). The Fund for the Replacement of Animals in Medical Experiments (FRAME): the first 25 years. ATLA 23, 19-32.
2. Balls, M. & Fentem, J.H. (1994). The Fund for the Replacement of Animals in Medical Experiments (FRAME): 23 years of campaigning for the Three Rs. In Alternatives to Animal Testing. New Ways in the Biomedical Sciences, Trends and Progress (ed. C.A. Reinhardt), pp. 45-55. Weinheim, Germany: VCH Verlag.
3. Balls, M., Goldberg, A.M., Fentem, J.H., Broadhead, C.L., Burch, R.L., Festing, M.F.W., Frazier, J.M., Hendriksen, C.F.M., Jennings, M., van der Kamp, M.D.O., Morton, D.B., Rowan, A.N., Russell, C., Russell, W.M.S., Spielmann, H., Stephens, M.L., Stokes, W.S., Straughan, D.W., Yager, J.D., Zurlo, J. & van Zutphen, B.F.M. (1995). The Three Rs: the way forward. The report and recommendations of ECVAM workshop 11. ATLA 23, 838-866.
4. Anon. (1982). Report of the FRAME Toxicity Committee. ATLA 10, 4-43.
5. Balls, M., Riddell, R.J. & Worden, A.N., eds (1983). Animals and Alternatives in Toxicity Testing, 550pp. London, UK and New York, NY, USA: Academic Press.
6. Anon. (1991). Animals and alternatives in toxicology: present status and future prospects (the second report of the FRAME Toxicity Committee). ATLA 19, 116-138.
7. Balls, M., Bridges, J. & Southee, J., eds (1991). Animals and Alternatives in Toxicology: Present Status and Future Prospects, 390pp. London, UK: Macmillan Press and New York, NY, USA: VCH Publishers.
8. Festing, M.F.W. (1998). The FRAME reduction initiative. ATLA 26, 377-378.
9. van Zeller, A-M. & Combes, R.D. (1999). Transgenic mouse bioassays for carcinogenicity testing: a step in the right direction? ATLA 27, 839-846.
10. Anon. (2001). An evaluation of alternatives to carcinogenicity testing. Toxicologic Pathology 29, S5.
11. Combes, R.D. (2000). The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. Toxicology in Vitro 14, 387-399.
12. Combes, R., Balls, M., Curren, R., Fischbach, M., Fusenig, N., Kirkland, D., Lasne, C., Landolph, J., LeBoeuf, R., Marquardt, H., McCormick, J., Müller, L., Rivedal, E., Sabbioni, E., Tanaka, N., Vasseur, P. & Yamasaki, H. (1999). Cell transformation assays as predictors of human carcinogenicity. The report and recommendations of ECVAM workshop 39. ATLA 27, 745-767.
13. Tsuchiya, T., Umeda, M., Nishiyama, H., Yoshimura, I., Ajimi, S., Asakura, M., Baba, H., Dewa, Y., Ebe, Y., Fushiwaki, Y., Hamada, S., Hamamura, T., Hayashi, M., Iwasa, Y., Kajiwara, Y., Ksahara, Y., Kawabata, M., Kitada, E., Kubo, K., Mashiko, K., Miura, D., Mizuhashi, F., Mizuno, F., Nakajima, M., Nakamura, Y., Nobe, N., Oishi, H., Ota, E., Sakai, A., Sato, M., Shimada, S., Sugiyama, T., Takahashi, C., Takeda, Y., Tanaka, N., Toyoizumi, C., Tsutsui, T., Wakuri, S., Yajima, S. & Yajima, N. (1999). An interlaboratory validation study of the improved transformation assay employing Balb/c 3T3 cells: results of a collaborative study on the two-stage cell transformation assay by the Non-genotoxic Carcinogen Study Group. ATLA 27, 685-702.
14. Combes, R.D. (2000). Endocrine disruptors: a critical review of in vitro and in vivo testing strategies for assessing their toxic hazard to humans. ATLA 28, 81-118.
15. Baker, V. (2001). Endocrine disruptors - testing strategies to assess human hazard. Toxicology in Vitro 15, 413-419.
16. Festing, M.F.W., Baumans, V., Combes, R.D., Halder, M., Hendriksen, C.F.M., Howard, B.R., Lovell, D.P., Moore, G.J., Overend, P. & Wilson, M.S. (1998). Reducing the use of laboratory animals in biomedical research: problems and possible solutions. The report and recommendations of ECVAM workshop 29. ATLA 26, 283-301.
17. Todd, M., Garthof, B., Bernhardt, W., Bodé, G., Farr, S., Kolar, R., Lumley, C., Pieters, M., Rogiers, V., Sauer, U., Spielmann, H., Straus, J. & Warngard, L. (1998). Issues relating to the release of proprietary information and data for use in the validation of alternative methods: The report and recommendations of ECVAM workshop 27. ATLA 26, 13-20.
18. Langley, G., Broadhead, C., Bottrill, K., Combes, R., Ewbank, R., Hawkins, P., Hubrecht, R., Jennings, M., Newman, C., Rowe, S., Southee, J., Todd, M. & Ward, L. (1999). Accessing information on the reduction, refinement and replacement of animal experiments. ATLA 27, 239-245.
19. Anon. (2001). White Paper: Strategy for a Future Chemicals Policy (COM(2001) 88 final. Web site: http://www.europa.eu.int/comm/environment/ chemicals/whitepaper.htm.
20. Combes, R.D. (2002). The EU White Paper: Strategy for a Future Chemicals Policy (an idea that must have seemed good at the time!). ATLA 30, 1-3.
21. Blaauboer, B.J., Bayliss, M.K., Castell, J.V., Evelo, C.T.A., Frazier, J.M., Groen, K., Gulden, M., Guillouzo, A., Hissink, A.M., Houston, J.B., Johanson, G., de Jongh, J., Kedderis, G.L., Reinhart, C.A., van de Sandt, J.J.M. & Semino, G. (1996). The use of biokinetics and in vitro methods in toxicological risk evaluation. The report and recommendations of ECVAM workshop 15. ATLA 24, 473-497.
22. Blaauboer, B.J., Barratt, M.D. & Houston, J.B. (1999). The integrated use of alternative methods in toxicological risk evaluation. ECVAM Integrated Testing Stategies Task Force Report 1. ATLA 27, 229-237.
23. Jenkins, E.S., Broadhead, C. & Combes, R.D. (2002). The implications of microarray technology for animal use in scientific research. ATLA 30, 459-465.
24. Fry, J. & George, E. (2001). In vitro toxicology in the light of new technologies. ATLA 29, 745-748.
25. Worth, A.P. & Cronin, M.T.D. (2004). Report of the workshop on the validation of QSARs and other computational prediction models. ATLA 32, Suppl. 1, 703-706.
26. Combes, R.D. & Judson, P. (1995). The use of artificial intelligence systems for predicting toxicity. Pesticide Science 45, 179-194.
27. Pfaller, W., Balls, M., Clothier, R., Coecke, S., Dierickx, P., Ekwall, B., Hanley, B.A., Hartung, T., Prieto, T., Ryan, M.P., Schmuck, G., Sladowski, D., Vericat, J-A., Wendel, A., Wolf, A. & Zimmer, J. (2001). Novel advanced in vitro methods for long term toxicity testing. The report and recommendations of ECVAM workshop 45. ATLA 29, 393-426.
28. Combes, R.D. (1999). Summary of discussion: in vitro models for investigation of chronic toxicity and reversibility. Toxicology in Vitro 13, 853-857.
29. Walker, C., Kaiser, K., Klein, W., Lagadic, L., Peakall, D., Sheffield, S., Soldan, T. & Yasuno, M. (1998). 13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): Alternatives testing methodologies for ecotoxicity. Environmental Health Perspectives 106, 441-451.
30. Repetto, G., Jos, A., Hazen, M.J., Molero, M.L., del Peso, A., Slaguero, M., del Castillo, P., Rodriquez-Vicente, M.C. & Repetto, M. (2001). A test battery for the ecotoxicological evaluation of pentachlorophenol. Toxicology in Vitro 15, 503-509.
31. Bottrill, K. (1998). The use of biomarkers as alternatives to current animal tests on food chemicals. ATLA 26, 421-480.
32. Broadhead, C.L. & Combes, R.D. (2001). The current status of food additives testing and the potential for the application of the Three Rs. ATLA 29, 471-486.
33. Combes, R., Balls. M., Bansil, L., Barratt, M., Bell, D., Botham, P., Broadhead, C., Clothier, R., George, E., Fentem, J., Jackson, M., Indans, I., Loizou, G., Navaratnam, V., Pentreath, V., Phillips, B., Stemplewski, H. & Stewart, J. (2002). An assessment of progress in the use of alternatives in toxicity testing since the publication of the report of the Second FRAME Toxicity Committee (1991). ATLA 30, 365-406.